We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Synthetic Compound Reverses Fatty Liver Disease In Lab Tests

December 19, 2012: 12:00 AM EST
Researchers in the U.S. report development of a synthetic compound that reverses the effects of fatty liver disease, a condition that often accompanies obesity and type 2 diabetes. SR9238 suppressed lipid (fat) production in the liver, eliminated inflammation and reversed fat accumulation in lab animals. According to the researchers, mice fed a high-fat diet and the compound for a month reversed the disease without side effects. The researchers also noted that markers for liver damage were also down, so the compound may be a potential treatment for alcohol-related fatty liver damage.
Kristine Griffett et al., "A Liver Selective LXR Inverse Agonist that Suppresses Hepatic Steatosis", ACS Chemical Biology, December 19, 2012, © American Chemical Society
Alternative Therapies
Cancer & Cancer Prevention
North America
United States of America
Innovation & New Ideas
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.